The bacterium Pseudomonas aeruginosa is among the most common causes of pneumonia and poses a major challenge to hospitals worldwide. The treatment of infections with Pseudomonas aeruginosa is usually challenging...
Therapeutically modified white blood cells hold great potential in the treatment of multiple myeloma, a malignant cancer of the bone marrow. However, they can lead to serious resistance in treated patients. In close...
An international research team of the Technische Universität Braunschweig and the Helmholtz Centre for Infection Research (HZI), led by the Department of Biotechnology of the TU Braunschweig, has reported on the...
The CoVerage tool analyses the lineage dynamics of SARS-CoV-2 strains, i.e. determines how successfully which virus strain spreads. The web resource uses input from the Gisaid genome database. Gisaid is an international...
The NoCovid group’s scientists, including HZI researchers Prof Melanie Brinkmann and Prof Michael Meyer-Hermann, have called for extensive testing, faster contact tracing, and a rapid rollout of vaccinations in Germany,...
With the outbreak of the COVID-19 pandemic, the HZI quickly moved into the public spotlight. Scientific Director Prof Dirk Heinz talks about one year of pandemic, the fast establishment of corona research and new...
“What exactly happens with infections in individual cells? How, where and when does the metabolism within infected cells change? If we manage to gain a better understanding of this, we’ll be able to find starting points...
Viruses have coexisted with mankind for a long time. The oldest genetic evidence of a viral disease shows that people already suffered from liver inflammation caused by hepatitis B viruses about 7,000 years ago. The...
As part of the adaptive immune system, T cells are involved in the defence against pathogens. However, if they recognise healthy, self-structures instead of invading pathogens, autoimmune diseases can result. It is...
